Tc-99m HMDP versus MDP discrepancy in cardiac amyloidosis

Joseph C Lee^{1

2}, Nathan Better^{3

4}

Affiliations

¹ Department of Medical Imaging, The Prince Charles Hospital, Chermside, QLD, 4032, Australia. joseph.lee@health.qld.gov.au.
² Faculty of Medicine, University of Queensland, Herston, Australia. joseph.lee@health.qld.gov.au.
³ Department of Nuclear Medicine, Royal Melbourne Hospital, Grattan St, Melbourne, VIC, 3000, Australia.
⁴ Department of Medicine, University of Melbourne, Parkville, Australia.

Comment

Joseph C Lee et al. J Nucl Cardiol. 2021 Oct.

. 2021 Oct;28(5):2424.

doi: 10.1007/s12350-021-02763-y. Epub 2021 Aug 13.

Joseph C Lee^{1

2}, Nathan Better^{3

4}

¹ Department of Medical Imaging, The Prince Charles Hospital, Chermside, QLD, 4032, Australia. joseph.lee@health.qld.gov.au.
² Faculty of Medicine, University of Queensland, Herston, Australia. joseph.lee@health.qld.gov.au.
³ Department of Nuclear Medicine, Royal Melbourne Hospital, Grattan St, Melbourne, VIC, 3000, Australia.
⁴ Department of Medicine, University of Melbourne, Parkville, Australia.

No abstract available

Comment on

Estimation of prevalence of transthyretin (ATTR) cardiac amyloidosis in an Australian subpopulation using bone scans with echocardiography and clinical correlation.
Cuscaden C, Ramsay SC, Prasad S, Goodwin B, Smith J. Cuscaden C, et al. J Nucl Cardiol. 2021 Dec;28(6):2845-2856. doi: 10.1007/s12350-020-02152-x. Epub 2020 May 8. J Nucl Cardiol. 2021. PMID: 32385832

1. Cuscaden C, Ramsay SC, Prasad S, Goodwin B, Smith J. Estimation of prevalence of transthyretin (ATTR) cardiac amyloidosis in an Australian subpopulation using bone scans with echocardiography and clinical correlation. J Nucl Cardiol. 2020. https://doi.org/10.1007/s12350-020-02152-x - DOI - PubMed
1. Lee JC, Hennessy AD, Khafagi FA. Bone scans. Aust Fam Phys 2012;41:689-92
1. Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M et al. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. J Nucl Cardiol 2019;26:2065-23 - DOI